GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » 5-Year Yield-on-Cost %

Consun Pharmaceutical Group (HKSE:01681) 5-Year Yield-on-Cost % : 18.54 (As of Jun. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group 5-Year Yield-on-Cost %?

Consun Pharmaceutical Group's yield on cost for the quarter that ended in Dec. 2023 was 18.54.


The historical rank and industry rank for Consun Pharmaceutical Group's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:01681' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.84   Med: 8.19   Max: 28.05
Current: 18.54


During the past 12 years, Consun Pharmaceutical Group's highest Yield on Cost was 28.05. The lowest was 1.84. And the median was 8.19.


HKSE:01681's 5-Year Yield-on-Cost % is ranked better than
97.01% of 501 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs HKSE:01681: 18.54

Competitive Comparison of Consun Pharmaceutical Group's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's 5-Year Yield-on-Cost % falls into.



Consun Pharmaceutical Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Consun Pharmaceutical Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Consun Pharmaceutical Group  (HKSE:01681) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Consun Pharmaceutical Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Executives
An Yubao 2101 Beneficial owner
Li Qian 2101 Beneficial owner
Central Success Developments Limited 2101 Beneficial owner
Aali Resources Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2301 Trustee
Zhang Lihua 2202 Interest of your spouse
An Meng 2101 Beneficial owner
Double Grace International Limited 2101 Beneficial owner
Bos Trustee Limited As Trustee 2201 Interest of corporation controlled by you

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines